Historical shareholding details of
Any Other
holdings in Bafna Pharmaceuticals Ltd. (BAFNAPH)
Quarterly changes of
Any Other
shareholding in Bafna Pharmaceuticals Ltd.
over the previous
quarters
|
Quarter
|
Name |
Total no. shares held |
No. of Holders |
Percent Holding |
Pledged
|
Locked
|
|
shares
|
%
|
shares
|
%
|
|
Dec 2024
|
Total
|
20,787,301
|
2
|
87.87%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2024
|
Total
|
20,787,301
|
2
|
87.87%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2024
|
Total
|
20,787,301
|
2
|
87.87%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2024
|
Total
|
20,787,301
|
2
|
87.87%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2023
|
Total
|
20,818,081
|
2
|
88.00%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2023
|
Total
|
20,891,482
|
2
|
88.31%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2023
|
Total
|
21,190,148
|
2
|
89.57%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2023
|
Total
|
21,190,148
|
2
|
89.57%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2022
|
Total
|
21,190,148
|
2
|
89.57%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2022
|
Total
|
21,190,148
|
2
|
89.57%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2022
|
Total
|
21,218,928
|
2
|
89.70%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2022
|
Total
|
21,292,690
|
2
|
90.01%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2021
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2021
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
|
|
|
|
Jun 2021
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
|
|
|
|
Mar 2021
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
|
|
|
|
Dec 2020
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
|
|
|
|
Sep 2020
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
|
|
|
|
Sep 10, 2020
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
Sep 10, 2020
|
Total
|
21,290,701
|
1
|
90.00%
|
0
|
0.00%
|
21,290,701
|
100.00%
|
|
|
|
|
|
Jun 2020
|
Total
|
624,504
|
8
|
26.40%
|
318,254
|
50.96%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2020
|
Total
|
367,837
|
4
|
15.55%
|
112,757
|
30.65%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2019
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2019
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2019
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2019
|
Total
|
3,280,268
|
3
|
13.87%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2018
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2018
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2018
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
-
|
0.00%
|
|
|
|
|
|
Mar 2018
|
Total
|
3,280,268
|
3
|
13.87%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2017
|
Total
|
3,280,268
|
3
|
17.58%
|
1,127,572
|
34.37%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2017
|
Total
|
3,438,503
|
4
|
18.43%
|
500,000
|
14.54%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2017
|
Total
|
3,438,503
|
4
|
18.43%
|
500,000
|
14.54%
|
627,572
|
18.25%
|
|
|
|
|
|
Dec 2016
|
Total
|
3,438,503
|
4
|
18.43%
|
500,000
|
14.54%
|
627,572
|
18.25%
|
|
|
|
|
|
Sep 2016
|
Total
|
3,438,503
|
4
|
18.43%
|
-
|
-%
|
627,572
|
18.25%
|
|
|
|
|
|
Jun 2016
|
Total
|
3,438,503
|
4
|
18.43%
|
-
|
-%
|
-
|
-%
|
|
|
|
|
|
Mar 2016
|
Total
|
4,038,503
|
4
|
21.65%
|
800,000
|
19.81%
|
-
|
-%
|
|
|
|
|
|
Dec 2015
|
Total
|
4,038,428
|
9
|
21.65%
|
800,000
|
19.81%
|
-
|
-%
|
View all shareholdings details of Bafna Pharmaceuticals Ltd.